Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Maiocchi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 25, 2006
Hepatotoxicity and antiretroviral therapy with protease inhibitors: A reviewR Bruno, P Sacchi, L Maiocchi, et al.
Parassitologia|August 13, 2004
[Overview of therapeutic options for cystic echinococcosis]E Brunetti, L Maiocchi, A L Garlaschelli, et al.
Biochemical Pharmacology|March 28, 2017
Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agentsSophie L Maiocchi, Jonathan C Morris, Martin D Rees, et al.
Free Radical Biology & Medicine|April 8, 2014
Mechanism and regulation of peroxidase-catalyzed nitric oxide consumption in physiological fluids: critical protective actions of ascorbate and thiocyanateMartin D Rees, Sophie L Maiocchi, Anthony J Kettle, et al.
Journal of Viral Hepatitis|January 12, 2012
Comparison of peginterferon pharmacokinetic and pharmacodynamic profilesR Bruno, P Sacchi, S Cima, et al.
Journal of Medicinal Chemistry|August 1, 1990
Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonistsM Turconi, M Nicola, M G Quintero, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 14, 2006
The current role of abdominal ultrasound in the clinical management of patients with AIDSE Brunetti, R Brigada, F Poletti, et al.
Pharmacology & Therapeutics|November 2, 2020
Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular diseaseSophie L Maiocchi, Jacqueline Ku, Thuan Thai, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled studyR Bruno, P Sacchi, C Scagnolari, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 25, 2006
Hepatotoxicity and antiretroviral therapy with protease inhibitors: A reviewR Bruno, P Sacchi, L Maiocchi, et al.
Parassitologia|August 13, 2004
[Overview of therapeutic options for cystic echinococcosis]E Brunetti, L Maiocchi, A L Garlaschelli, et al.
Biochemical Pharmacology|March 28, 2017
Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agentsSophie L Maiocchi, Jonathan C Morris, Martin D Rees, et al.
Free Radical Biology & Medicine|April 8, 2014
Mechanism and regulation of peroxidase-catalyzed nitric oxide consumption in physiological fluids: critical protective actions of ascorbate and thiocyanateMartin D Rees, Sophie L Maiocchi, Anthony J Kettle, et al.
Journal of Viral Hepatitis|January 12, 2012
Comparison of peginterferon pharmacokinetic and pharmacodynamic profilesR Bruno, P Sacchi, S Cima, et al.
Journal of Medicinal Chemistry|August 1, 1990
Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonistsM Turconi, M Nicola, M G Quintero, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 14, 2006
The current role of abdominal ultrasound in the clinical management of patients with AIDSE Brunetti, R Brigada, F Poletti, et al.
Pharmacology & Therapeutics|November 2, 2020
Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular diseaseSophie L Maiocchi, Jacqueline Ku, Thuan Thai, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled studyR Bruno, P Sacchi, C Scagnolari, et al.
Pageof 1